Logo do repositório
 
Publicação

Antioxidant activity of myrtus communis l. and myrtus nivellei batt. & trab. extracts: a brief review

datacite.subject.sdg03:Saúde de Qualidade
datacite.subject.sdg15:Proteger a Vida Terrestre
datacite.subject.sdg12:Produção e Consumo Sustentáveis
dc.contributor.authorHennia, Aicha
dc.contributor.authorMiguel, Maria da Graça
dc.contributor.authorNemmiche, Said
dc.date.accessioned2026-02-24T09:54:49Z
dc.date.available2026-02-24T09:54:49Z
dc.date.issued2018-08-11
dc.description.abstractMyrtus communis L. (myrtle) and Myrtus nivellei Batt. & Trab. (Saharan myrtle) have been used in folk medicine for alleviating some ailments. M. communis is largely distributed in the Mediterranean Basin, whereas M. nivellei is confined in specific zones of the central Saharan mountains. The chemical composition and antioxidant activity of berry and leaf extracts isolated from myrtle are deeply documented, whereas those isolated from Saharan myrtle extracts are less studied. In both species, the major groups of constituents include gallic acid derivatives, flavonols, flavonol derivatives, and hydroxybenzoic acids. In coloured berries, anthocyanins are also present. In M. nivellei extracts are reported for some compounds not described in M. communis so far: 2-hydroxy-1,8-cineole-β-D-glucopyranoside, 2-hydroxy-1,8-cineole 2-O-α-L-arabinofuranosyl (1→6)-β-D-glucopyranoside, rugosin A, and rugosin B. Berries and leaves extracts of both species had antioxidant activity. Comparative studies of the antioxidant activity between leaf and berry myrtle extracts revealed that leaf extracts are best antioxidants, which can be assigned to the galloyl derivatives, flavonols, and flavonols derivatives, although the ratio of these groups of compounds might also have an important role in the antioxidant activity. The anthocyanins present in myrtle berries seem to possess weak antioxidant activity. The antioxidant activity of sample extracts depended on various factors: harvesting time, storage, extraction solvent, extraction type, and plant part used, among other factors. Leaf extracts of myrtle revealed to possess anti-inflammatory activity in several models used. This property has been attributed either to the flavonoids and/or hydrolysable tannins, nevertheless nonprenylated acylphloroglucinols (e.g., myrtucommulone and semimyrtucommulone) have also revealed a remarkable role in that activity. The biological activities of myrtle extracts found so far may direct its use towards for stabilizing complex lipid systems, as prebiotic in food formulations, and as novel therapeutic for the management of inflammation.eng
dc.identifier.doi10.3390/medicines5030089
dc.identifier.issn2305-6320
dc.identifier.urihttp://hdl.handle.net/10400.1/28227
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relationCenter for Mediterranean Bioresources and food
dc.relation.ispartofMedicines
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAnti-inflammatory
dc.subjectBerries
dc.subjectLeaves
dc.subjectGalloyl derivatives
dc.subjectFlavonol derivatives
dc.subjectAnthocyanins
dc.subjectMyrtucommulone
dc.titleAntioxidant activity of myrtus communis l. and myrtus nivellei batt. & trab. extracts: a brief revieweng
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberUID/BIA/04325/2013
oaire.awardTitleCenter for Mediterranean Bioresources and food
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIA%2F04325%2F2013/PT
oaire.citation.issue3
oaire.citation.startPage89
oaire.citation.titleMedicine
oaire.citation.volume5
oaire.fundingStream6817 - DCRRNI ID
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameMiguel
person.givenNameMaria da Graça
person.identifier.ciencia-id6110-6FE7-DF28
person.identifier.orcid0000-0003-2507-4228
person.identifier.scopus-author-id35562054500
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
relation.isAuthorOfPublication2507350f-9e60-4d4a-a096-53e58d93549c
relation.isAuthorOfPublication.latestForDiscovery2507350f-9e60-4d4a-a096-53e58d93549c
relation.isProjectOfPublication4556bdc1-a62e-4c34-9ffe-a907cb01ed01
relation.isProjectOfPublication.latestForDiscovery4556bdc1-a62e-4c34-9ffe-a907cb01ed01

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
medicines-05-00089-v2.pdf
Tamanho:
641.19 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
3.46 KB
Formato:
Item-specific license agreed upon to submission
Descrição: